IMNN CIK: 749647

Imunon, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
51.9
FY22:
36.8
FY23:
18.2
FY24:
8.01
FY25:
10.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
22.1
FY22:
7.20
FY23:
3.68
FY24:
1.71
FY25:
1.56
Total assets
Change from FY21 to FY25
millions USD
FY21:
74.0
FY22:
44.0
FY23:
21.9
FY24:
9.72
FY25:
12.3

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
6.77
FY22:
10.0
FY23:
7.39
FY24:
4.79
FY25:
4.62
(negative)
Change from FY21 to FY25
millions USD
FY21:
11.5
FY22:
4.61
FY23:
1.14
FY24:
0.69
FY25:
0.60
(positive)
Change from FY21 to FY25
millions USD
FY21:
55.8
FY22:
29.3
FY23:
13.4
FY24:
4.24
FY25:
7.06
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
74.0
FY22:
44.0
FY23:
21.9
FY24:
9.72
FY25:
12.3

All amounts in millions USD Data source:SEC EDGAR